{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:23:33Z","timestamp":1788593013166,"version":"build-2803163510"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"publisher","award":["110875"],"award-info":[{"award-number":["110875"]}],"id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"publisher","award":["110825"],"award-info":[{"award-number":["110825"]}],"id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.03-2019-07"],"award-info":[{"award-number":["WE.03-2019-07"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autosomal dominant variants in <jats:italic>LRP10<\/jats:italic> have been identified in patients with Lewy body diseases (LBDs), including Parkinson\u2019s disease (PD), Parkinson\u2019s disease-dementia (PDD), and dementia with Lewy bodies (DLB). Nevertheless, there is little mechanistic insight into the role of LRP10 in disease pathogenesis. In the brains of control individuals, LRP10 is typically expressed in non-neuronal cells like astrocytes and neurovasculature, but in idiopathic and genetic cases of PD, PDD, and DLB, it is also present in \u03b1-synuclein-positive neuronal Lewy bodies. These observations raise the questions of what leads to the accumulation of LRP10 in Lewy bodies and whether a possible interaction between LRP10 and \u03b1-synuclein plays a role in disease pathogenesis. Here, we demonstrate that wild-type LRP10 is secreted via extracellular vesicles (EVs) and can be internalised via clathrin-dependent endocytosis. Additionally, we show that LRP10 secretion is highly sensitive to autophagy inhibition, which induces the formation of atypical LRP10 vesicular structures in neurons in human-induced pluripotent stem cells (iPSC)-derived brain organoids. Furthermore, we show that LRP10 overexpression leads to a strong induction of monomeric \u03b1-synuclein secretion, together with time-dependent, stress-sensitive changes in intracellular \u03b1-synuclein levels. Interestingly, patient-derived astrocytes carrying the <jats:italic>c.1424<\/jats:italic>\u2009+\u2009<jats:italic>5G<\/jats:italic>\u2009&gt;\u2009<jats:italic>A LRP10<\/jats:italic> variant secrete aberrant high-molecular-weight species of LRP10 in EV-free media fractions. Finally, we show that this truncated patient-derived LRP10 protein species (LRP10<jats:sup>splice<\/jats:sup>) binds to wild-type LRP10, reduces LRP10 wild-type levels, and antagonises the effect of LRP10 on \u03b1-synuclein levels and distribution. Together, this work provides initial evidence for a possible functional role of LRP10 in LBDs by modulating intra- and extracellular \u03b1-synuclein levels, and pathogenic mechanisms linked to the disease-associated <jats:italic>c.1424<\/jats:italic>\u2009+\u2009<jats:italic>5G<\/jats:italic>\u2009&gt;\u2009<jats:italic>A LRP10<\/jats:italic> variant, pointing towards potentially important disease mechanisms in LBDs.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s00018-024-05135-0","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T10:02:17Z","timestamp":1707127337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["LRP10 and \u03b1-synuclein transmission in Lewy body diseases"],"prefix":"10.1007","volume":"81","author":[{"given":"Ana","family":"Carreras Mascaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna M.","family":"Grochowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Boumeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja F. J.","family":"Dits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece Naz","family":"Bilgi\u04ab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido J.","family":"Breedveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Vergouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Jan","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"van Royen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bonifati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2673-5972","authenticated-orcid":false,"given":"Wim","family":"Mandemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"issue":"2","key":"5135_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141(2):159\u2013172","journal-title":"Acta Neuropathol"},{"issue":"5","key":"5135_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480","journal-title":"Lancet Neurol"},{"issue":"S1","key":"5135_CR3","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan DB, Fiest KM, Roberts JI, Maxwell CJ, Dykeman J, Pringsheim T et al (2016) The prevalence and incidence of dementia with lewy bodies: a systematic review. Can J Neurol Sci 43(S1):S83\u2013S95","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"5135_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","volume":"70","author":"MA Nalls","year":"2013","unstructured":"Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF et al (2013) A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 70(6):727\u2013735","journal-title":"JAMA Neurol"},{"key":"5135_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","volume":"22","author":"T Konno","year":"2016","unstructured":"Konno T, Ross OA, Puschmann A, Dickson DW, Wszolek ZK (2016) Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications. Parkinsonism Relat Disord 22:S1\u2013S6","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"5135_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD et al (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17(1):64\u201374","journal-title":"Lancet Neurol"},{"issue":"11","key":"5135_CR7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11(11):986\u2013998","journal-title":"Lancet Neurol"},{"issue":"5","key":"5135_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/gps.5260","volume":"35","author":"H Sanghvi","year":"2020","unstructured":"Sanghvi H, Singh R, Morrin H, Rajkumar AP (2020) Systematic review of genetic association studies in people with Lewy body dementia. Int J Geriatr Psychiatry 35(5):436\u2013448","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"5135_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","volume":"17","author":"M Quadri","year":"2018","unstructured":"Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E et al (2018) LRP10 genetic variants in familial Parkinson\u2019s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol 17(7):597\u2013608","journal-title":"Lancet Neurol"},{"key":"5135_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00054","author":"T Pohlkamp","year":"2017","unstructured":"Pohlkamp T, Wasser CR, Herz J (2017) Functional roles of the interaction of APP and lipoprotein receptors. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2017.00054","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"5135_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00401-021-02313-3","volume":"142","author":"MM Grochowska","year":"2021","unstructured":"Grochowska MM, Carreras Mascaro A, Boumeester V, Natale D, Breedveld GJ, Geut H et al (2021) LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 142(1):117\u2013137","journal-title":"Acta Neuropathol"},{"issue":"8","key":"5135_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1600-0854.2009.00933.x","volume":"10","author":"J Brodeur","year":"2009","unstructured":"Brodeur J, Larkin H, Boucher R, Th\u00e9riault C, St-Louis SC, Gagnon H et al (2009) Calnuc binds to LRP9 and affects its endosomal sorting. Traffic 10(8):1098\u20131114","journal-title":"Traffic"},{"issue":"9","key":"5135_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/j.1600-0854.2008.00786.x","volume":"9","author":"B Doray","year":"2008","unstructured":"Doray B, Knisely JM, Wartman L, Bu G, Kornfeld S (2008) Identification of acidic dileucine signals in LRP9 that interact with both GGAs and AP-1\/AP-2. Traffic 9(9):1551\u20131562","journal-title":"Traffic"},{"issue":"2","key":"5135_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00418-008-0436-5","volume":"130","author":"R Boucher","year":"2008","unstructured":"Boucher R, Larkin H, Brodeur J, Gagnon H, Th\u00e9riault C, Lavoie C (2008) Intracellular trafficking of LRP9 is dependent on two acidic cluster\/dileucine motifs. Histochem Cell Biol 130(2):315\u2013327","journal-title":"Histochem Cell Biol"},{"issue":"5","key":"5135_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/ncb2721","volume":"15","author":"F Steinberg","year":"2013","unstructured":"Steinberg F, Gallon M, Winfield M, Thomas EC, Bell AJ, Heesom KJ et al (2013) A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport. Nat Cell Biol 15(5):461\u2013471","journal-title":"Nat Cell Biol"},{"key":"5135_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.parkreldis.2019.05.037","volume":"65","author":"LJM Vergouw","year":"2019","unstructured":"Vergouw LJM, Ruitenberg A, Wong TH, Melhem S, Breedveld GJ, Criscuolo C et al (2019) LRP10 variants in Parkinson\u2019s disease and dementia with Lewy bodies in the South-West of the Netherlands. Parkinsonism Relat Disord 65:243\u2013247","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"5135_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3233\/JAD-200318","volume":"76","author":"LJM Vergouw","year":"2020","unstructured":"Vergouw LJM, Geut H, Breedveld G, Kuipers DJS, Quadri M, Netherlands Brain B et al (2020) Clinical and pathological phenotypes of LRP10 variant carriers with dementia. J Alzheimers Dis 76(3):1161\u20131170","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"5135_CR18","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/mds.27693","volume":"34","author":"Y Chen","year":"2019","unstructured":"Chen Y, Cen Z, Zheng X, Pan Q, Chen X, Zhu L et al (2019) LRP10 in autosomal-dominant Parkinson\u2019s disease. Mov Disord 34(6):912\u2013916","journal-title":"Mov Disord"},{"issue":"7","key":"5135_CR19","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/brain\/awaa167","volume":"143","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Qin L, Pan H, Liu Z, Jiang L, He Y et al (2020) The role of genetics in Parkinson\u2019s disease: a large cohort study in Chinese mainland population. Brain 143(7):2220\u20132234","journal-title":"Brain"},{"issue":"3","key":"5135_CR20","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s12035-020-02186-9","volume":"58","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Ning P, Yang X, Shi C, Xu Y, Shen Q et al (2021) LRP10 mutations may correlate with sporadic Parkinson\u2019s disease in China. Mol Neurobiol 58(3):1212\u20131216","journal-title":"Mol Neurobiol"},{"issue":"99","key":"5135_CR21","first-page":"e1","volume":"99","author":"C Li","year":"2021","unstructured":"Li C, Chen Y, Ou R, Gu X, Wei Q, Cao B et al (2021) Mutation analysis of LRP10 in a large Chinese familial Parkinson disease cohort. Neurobiol Aging 99(99):e1\u2013e6","journal-title":"Neurobiol Aging"},{"key":"5135_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06496-9","author":"N Song","year":"2022","unstructured":"Song N, Wang Y, Zhou L, Zhang J, Wu F, Li M et al (2022) Genetic analysis of the LRP10 gene in Chinese patients with Parkinson\u2019s disease. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-022-06496-9","journal-title":"Neurol Sci"},{"issue":"9","key":"5135_CR23","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1093\/brain\/awz191","volume":"142","author":"MMX Tan","year":"2019","unstructured":"Tan MMX, Malek N, Lawton MA, Hubbard L, Pittman AM, Joseph T et al (2019) Genetic analysis of Mendelian mutations in a large UK population-based Parkinson\u2019s disease study. Brain 142(9):2828\u20132844","journal-title":"Brain"},{"key":"5135_CR24","doi-asserted-by":"publisher","first-page":"311.e5","DOI":"10.1016\/j.neurobiolaging.2020.04.016","volume":"94","author":"LJM Vergouw","year":"2020","unstructured":"Vergouw LJM, Melhem S, Donker Kaat L, Chiu WZ, Kuipers DJS, Breedveld G et al (2020) LRP10 variants in progressive supranuclear palsy. Neurobiol Aging 94:311.e5-e.10","journal-title":"Neurobiol Aging"},{"key":"5135_CR25","doi-asserted-by":"publisher","first-page":"145.e17","DOI":"10.1016\/j.neurobiolaging.2020.06.013","volume":"97","author":"J Ni","year":"2021","unstructured":"Ni J, Liu Z, Li W, Yuan Y, Huang L, Hu Y et al (2021) Rare, pathogenic variants in LRP10 are associated with amyotrophic lateral sclerosis in patients from mainland China. Neurobiol Aging 97:145.e17-e22","journal-title":"Neurobiol Aging"},{"key":"5135_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1326-7-31","volume":"7","author":"J Brodeur","year":"2012","unstructured":"Brodeur J, Th\u00e9riault C, Lessard-Beaudoin M, Marcil A, Dahan S, Lavoie C (2012) LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer\u2019s disease. Mol Neurodegener 7:31","journal-title":"Mol Neurodegener"},{"issue":"51","key":"5135_CR27","doi-asserted-by":"publisher","first-page":"15817","DOI":"10.1021\/bi001583s","volume":"39","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kumagai H, Morikawa Y, Wada Y, Sugiyama A, Yasuda K et al (2000) A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro. Biochemistry 39(51):15817\u201315825","journal-title":"Biochemistry"},{"key":"5135_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb5398","author":"RA Neff","year":"2021","unstructured":"Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q et al (2021) Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abb5398","journal-title":"Sci Adv"},{"issue":"4","key":"5135_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VMY (2020) Protein transmission in neurodegenerative disease. Nat Rev Neurol 16(4):199\u2013212","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"5135_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Rohan de Silva HA et al (1995) The precursor protein of non-A\u03b2 component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14(2):467\u2013475","journal-title":"Neuron"},{"issue":"5999","key":"5135_CR31","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, S\u00fcdhof TC (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329(5999):1663\u20131667","journal-title":"Science"},{"issue":"3","key":"5135_CR32","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J Burr\u00e9","year":"2018","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2018) Cell biology and pathophysiology of \u03b1-synuclein. Cold Spring Harbor Perspect Med 8(3):a024091","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"6","key":"5135_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","volume":"21","author":"DF Clayton","year":"1998","unstructured":"Clayton DF, George JM (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21(6):249\u2013254","journal-title":"Trends Neurosci"},{"key":"5135_CR34","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/s41593-023-01474-6","volume":"26","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhu R, Pan B, Xu H, Olufemi MF, Gathagan RJ et al (2023) Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein. Nat Neurosci 26:2250","journal-title":"Nat Neurosci"},{"key":"5135_CR35","doi-asserted-by":"publisher","first-page":"168011","DOI":"10.1016\/j.jmb.2023.168011","volume":"435","author":"RWL So","year":"2023","unstructured":"So RWL, Watts JC (2023) \u03b1-Synuclein conformational strains as drivers of phenotypic heterogeneity in neurodegenerative diseases. J Mol Biol 435:168011","journal-title":"J Mol Biol"},{"issue":"47","key":"5135_CR36","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR et al (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106(47):20051\u201320056","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5135_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A et al (2011) Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72(1):57\u201371","journal-title":"Neuron"},{"issue":"7706","key":"5135_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557(7706):558\u2013563","journal-title":"Nature"},{"issue":"2","key":"5135_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"29","key":"5135_CR40","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW et al (2014) Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A 111(29):10732\u201310737","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"5135_CR41","doi-asserted-by":"publisher","first-page":"9182","DOI":"10.1128\/JVI.01399-16","volume":"90","author":"S Breid","year":"2016","unstructured":"Breid S, Bernis ME, Babila JT, Garza MC, Wille H, Tamg\u00fcney G (2016) Neuroinvasion of \u03b1-synuclein prionoids after intraperitoneal and intraglossal inoculation. J Virol 90(20):9182\u20139193","journal-title":"J Virol"},{"issue":"2","key":"5135_CR42","doi-asserted-by":"publisher","first-page":"e02095","DOI":"10.1128\/JVI.02095-16","volume":"91","author":"JI Ayers","year":"2017","unstructured":"Ayers JI, Brooks MM, Rutherford NJ, Howard JK, Sorrentino ZA, Riffe CJ et al (2017) Robust central nervous system pathology in transgenic mice following peripheral injection of \u03b1-synuclein fibrils. J Virol 91(2):e02095","journal-title":"J Virol"},{"issue":"1","key":"5135_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2018) Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 13(1):21","journal-title":"Mol Neurodegener"},{"issue":"19","key":"5135_CR44","doi-asserted-by":"publisher","first-page":"e4521","DOI":"10.21769\/BioProtoc.4521","volume":"12","author":"MM Grochowska","year":"2022","unstructured":"Grochowska MM, Bonifati V, Mandemakers W (2022) CRISPR\/Cas9-mediated LRP10 Knockout in HuTu-80 and HEK 293T Cell Lines. Bio-Protoc 12(19):e4521","journal-title":"Bio-Protoc"},{"issue":"13","key":"5135_CR45","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMsr040330","volume":"350","author":"CA Cowan","year":"2004","unstructured":"Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP et al (2004) Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350(13):1353\u20131356","journal-title":"N Engl J Med"},{"issue":"4","key":"5135_CR46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.stem.2016.01.022","volume":"18","author":"MA Mandegar","year":"2016","unstructured":"Mandegar MA, Huebsch N, Frolov EB, Shin E, Truong A, Olvera MP et al (2016) CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs. Cell Stem Cell 18(4):541\u2013553","journal-title":"Cell Stem Cell"},{"issue":"10","key":"5135_CR47","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.15252\/embj.201695773","volume":"36","author":"R Vanhauwaert","year":"2017","unstructured":"Vanhauwaert R, Kuenen S, Masius R, Bademosi A, Manetsberger J, Schoovaerts N et al (2017) The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals. Embo J 36(10):1392\u20131411","journal-title":"Embo J"},{"issue":"2","key":"5135_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.stemcr.2014.12.012","volume":"4","author":"TS Barakat","year":"2015","unstructured":"Barakat TS, Ghazvini M, de Hoon B, Li T, Eussen B, Douben H et al (2015) Stable X chromosome reactivation in female human induced pluripotent stem cells. Stem cell reports 4(2):199\u2013208","journal-title":"Stem cell reports"},{"issue":"3","key":"5135_CR49","doi-asserted-by":"publisher","first-page":"e59252-e","DOI":"10.1371\/journal.pone.0059252","volume":"8","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt P, Glatza M, Hemmer K, Tsytsyura Y, Thiel CS, H\u00f6ing S et al (2013) Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE 8(3):e59252-e","journal-title":"PLoS ONE"},{"key":"5135_CR50","doi-asserted-by":"publisher","first-page":"e52904","DOI":"10.7554\/eLife.52904","volume":"9","author":"H Renner","year":"2020","unstructured":"Renner H, Grabos M, Becker KJ, Kagermeier TE, Wu J, Otto M et al (2020) A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. Elife 9:e52904","journal-title":"Elife"},{"issue":"5","key":"5135_CR51","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel AS, Smits LM, Hemmer K, Hachi S, Moreno EL, van Wuellen T et al (2017) Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Rep 8(5):1144\u20131154","journal-title":"Stem Cell Rep"},{"issue":"8","key":"5135_CR52","doi-asserted-by":"publisher","first-page":"e23939","DOI":"10.1371\/journal.pone.0023939","volume":"6","author":"BR Lee","year":"2011","unstructured":"Lee BR, Kamitani T (2011) Improved immunodetection of endogenous \u03b1-synuclein. PLoS ONE 6(8):e23939","journal-title":"PLoS ONE"},{"key":"5135_CR53","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.21.348375","author":"TA Hartjes","year":"2020","unstructured":"Hartjes TA, Slotman JA, Vredenbregt MS, Dits N, Van der Meel R, Duijvesz D et al (2020) EVQuant; high-throughput quantification and characterization of extracellular vesicle (sub)populations. bioRxiv. https:\/\/doi.org\/10.1101\/2020.10.21.348375","journal-title":"bioRxiv"},{"issue":"1","key":"5135_CR54","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesic 7(1):1535750","journal-title":"J Extracell Vesic"},{"issue":"1","key":"5135_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD et al (2016) Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89(1):37\u201353","journal-title":"Neuron"},{"issue":"2","key":"5135_CR56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.09.027","volume":"167","author":"G La Manno","year":"2016","unstructured":"La Manno G, Gyllborg D, Codeluppi S, Nishimura K, Salto C, Zeisel A et al (2016) Molecular diversity of midbrain development in mouse, human, and stem cells. Cell 167(2):566\u201380.e19","journal-title":"Cell"},{"issue":"3","key":"5135_CR57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.neuron.2020.05.014","volume":"107","author":"L Barbar","year":"2020","unstructured":"Barbar L, Jain T, Zimmer M, Kruglikov I, Sadick JS, Wang M et al (2020) CD49f is a novel marker of functional and reactive human iPSC-derived astrocytes. Neuron 107(3):436\u201353.e12","journal-title":"Neuron"},{"issue":"6","key":"5135_CR58","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10(6):839\u2013850","journal-title":"Dev Cell"},{"issue":"4","key":"5135_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.spen.2013.10.003","volume":"20","author":"LS Chaboub","year":"2013","unstructured":"Chaboub LS, Deneen B (2013) Astrocyte form and function in the developing central nervous system. Semin Pediatr Neurol 20(4):230\u2013235","journal-title":"Semin Pediatr Neurol"},{"issue":"12","key":"5135_CR60","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1371\/journal.pbio.0050325","volume":"5","author":"R Kittappa","year":"2007","unstructured":"Kittappa R, Chang WW, Awatramani RB, McKay RD (2007) The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol 5(12):e325","journal-title":"PLoS Biol"},{"issue":"2","key":"5135_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/jnc.13745","volume":"139","author":"JM Bin","year":"2016","unstructured":"Bin JM, Harris SN, Kennedy TE (2016) The oligodendrocyte-specific antibody \u201cCC1\u201d binds Quaking 7. J Neurochem 139(2):181\u2013186","journal-title":"J Neurochem"},{"issue":"8","key":"5135_CR62","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Fiesel FC, Springer W (2020) Autophagy in Parkinson\u2019s disease. J Mol Biol 432(8):2651\u20132672","journal-title":"J Mol Biol"},{"issue":"7","key":"5135_CR63","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41419-018-0816-2","volume":"9","author":"N Fussi","year":"2018","unstructured":"Fussi N, H\u00f6llerhage M, Chakroun T, Nyk\u00e4nen NP, R\u00f6sler TW, Koeglsperger T et al (2018) Exosomal secretion of \u03b1-synuclein as protective mechanism after upstream blockage of macroautophagy. Cell Death Dis 9(7):757","journal-title":"Cell Death Dis"},{"issue":"20","key":"5135_CR64","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838\u20136851","journal-title":"J Neurosci"},{"issue":"15","key":"5135_CR65","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi Y, Andhey PS, Ising C, Wang K, Snipes LL, Boyer K et al (2021) Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron 109(15):2413\u201326 e7","journal-title":"Neuron"},{"issue":"7803","key":"5135_CR66","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE et al (2020) LRP1 is a master regulator of tau uptake and spread. Nature 580(7803):381\u2013385","journal-title":"Nature"},{"key":"5135_CR67","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM, Lathuiliere A, Migliorini M, Arai AL, Wani MM, Dujardin S et al (2021) Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. J Biol Chem 296:100715","journal-title":"J Biol Chem"},{"issue":"1","key":"5135_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","volume":"17","author":"K Chen","year":"2022","unstructured":"Chen K, Martens YA, Meneses A, Ryu DH, Lu W, Raulin AC et al (2022) LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread. Mol Neurodegener 17(1):57","journal-title":"Mol Neurodegener"},{"issue":"28","key":"5135_CR69","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1523\/JNEUROSCI.0250-20.2020","volume":"40","author":"H Zhang","year":"2020","unstructured":"Zhang H, Chen W, Tan Z, Zhang L, Dong Z, Cui W et al (2020) A role of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytic A\u03b2 clearance. J Neurosci 40(28):5347\u20135361","journal-title":"J Neurosci"},{"issue":"2","key":"5135_CR70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39(2):168\u2013177","journal-title":"Nat Genet"},{"key":"5135_CR71","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/brain\/awac414","volume":"146","author":"R Real","year":"2022","unstructured":"Real R, Martinez-Carrasco A, Reynolds RH, Lawton MA, Tan MMX, Shoai M et al (2022) Association between the LRP1B and APOE loci in the development of Parkinson\u2019s disease dementia. Brain 146:1873\u20131887","journal-title":"Brain"},{"key":"5135_CR72","doi-asserted-by":"publisher","first-page":"120700","DOI":"10.1016\/j.biomaterials.2021.120700","volume":"271","author":"C Chun","year":"2021","unstructured":"Chun C, Smith AST, Kim H, Kamenz DS, Lee JH, Lee JB et al (2021) Astrocyte-derived extracellular vesicles enhance the survival and electrophysiological function of human cortical neurons in vitro. Biomaterials 271:120700","journal-title":"Biomaterials"},{"issue":"5","key":"5135_CR73","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C et al (2014) Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol 128(5):639\u2013650","journal-title":"Acta Neuropathol"},{"issue":"47","key":"5135_CR74","doi-asserted-by":"publisher","first-page":"9269","DOI":"10.1523\/JNEUROSCI.0147-18.2019","volume":"39","author":"AF Hill","year":"2019","unstructured":"Hill AF (2019) Extracellular vesicles and neurodegenerative diseases. J Neurosci 39(47):9269\u20139273","journal-title":"J Neurosci"},{"issue":"Pt 2","key":"5135_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM et al (2016) Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain 139(Pt 2):481\u2013494","journal-title":"Brain"},{"key":"5135_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L et al (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42","journal-title":"Mol Neurodegener"},{"issue":"3\u20134","key":"5135_CR77","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/prca.201400114","volume":"9","author":"S Boukouris","year":"2015","unstructured":"Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl 9(3\u20134):358\u2013367","journal-title":"Proteomics Clin Appl"},{"issue":"3","key":"5135_CR78","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ et al (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42(3):360\u2013367","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5135_CR79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K et al (2018) Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy 14(1):98\u2013119","journal-title":"Autophagy"},{"issue":"1","key":"5135_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119(1):7\u201335","journal-title":"Acta Neuropathol"},{"issue":"4458","key":"5135_CR81","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.7403847","volume":"209","author":"GA Banker","year":"1980","unstructured":"Banker GA (1980) Trophic interactions between astroglial cells and hippocampal neurons in culture. Science 209(4458):809\u2013810","journal-title":"Science"},{"issue":"3","key":"5135_CR82","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","volume":"96","author":"NJ Allen","year":"2017","unstructured":"Allen NJ, Eroglu C (2017) Cell biology of astrocyte\u2013synapse interactions. Neuron 96(3):697\u2013708","journal-title":"Neuron"},{"issue":"1","key":"5135_CR83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41\u201353","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"5135_CR84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Mu\u00f1oz JP, Richaud-Patin Y et al (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep 12(2):213\u2013229","journal-title":"Stem Cell Rep"},{"issue":"12","key":"5135_CR85","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncpneuro0355","volume":"2","author":"NJ Maragakis","year":"2006","unstructured":"Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2(12):679\u2013689","journal-title":"Nat Clin Pract Neurol"},{"issue":"7638","key":"5135_CR86","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487","journal-title":"Nature"},{"issue":"6","key":"5135_CR87","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth HDE, Hirst WD, Wade-Martins R (2017) The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci 40(6):358\u2013370","journal-title":"Trends Neurosci"},{"issue":"1","key":"5135_CR88","doi-asserted-by":"publisher","first-page":"28823","DOI":"10.1038\/srep28823","volume":"6","author":"J-M Kim","year":"2016","unstructured":"Kim J-M, Cha S-H, Choi YR, Jou I, Joe E-H, Park SM (2016) DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression. Sci Rep 6(1):28823","journal-title":"Sci Rep"},{"issue":"2","key":"5135_CR89","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"R Bandopadhyay","year":"2004","unstructured":"Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD et al (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 127(2):420\u2013430","journal-title":"Brain"},{"issue":"5","key":"5135_CR90","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/glia.22475","volume":"61","author":"I Choi","year":"2013","unstructured":"Choi I, Kim J, Jeong HK, Kim B, Jou I, Park SM et al (2013) PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR. Glia 61(5):800\u2013812","journal-title":"Glia"},{"issue":"5","key":"5135_CR91","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/mds.27994","volume":"35","author":"A Sanyal","year":"2020","unstructured":"Sanyal A, DeAndrade MP, Novis HS, Lin S, Chang J, Lengacher N et al (2020) Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by LRRK2 inhibition. Mov Disord 35(5):760\u2013773","journal-title":"Mov Disord"},{"issue":"1","key":"5135_CR92","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-3-12","volume":"3","author":"X-L Gu","year":"2010","unstructured":"Gu X-L, Long C-X, Sun L, Xie C, Lin X, Cai H (2010) Astrocytic expression of Parkinson\u2019s disease-related A53T \u03b1-synuclein causes neurodegeneration in mice. Mol Brain 3(1):12","journal-title":"Mol Brain"},{"issue":"21","key":"5135_CR93","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","volume":"24","author":"AG Henry","year":"2015","unstructured":"Henry AG, Aghamohammadzadeh S, Samaroo H, Chen Y, Mou K, Needle E et al (2015) Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum Mol Genet 24(21):6013\u20136028","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5135_CR94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"R Mazzulli Joseph","year":"2011","unstructured":"Mazzulli Joseph R, Xu Y-H, Sun Y, Knight Adam L, McLean Pamela J, Caldwell Guy A et al (2011) Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146(1):37\u201352","journal-title":"Cell"},{"issue":"20","key":"5135_CR95","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1523\/JNEUROSCI.6194-10.2011","volume":"31","author":"S Anwar","year":"2011","unstructured":"Anwar S, Peters O, Millership S, Ninkina N, Doig N, Connor-Robson N et al (2011) Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci 31(20):7264","journal-title":"J Neurosci"},{"issue":"45","key":"5135_CR96","doi-asserted-by":"publisher","first-page":"19573","DOI":"10.1073\/pnas.1005005107","volume":"107","author":"B Greten-Harrison","year":"2010","unstructured":"Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, Nie EH et al (2010) \u03b1\u03b2\u03b3-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 107(45):19573\u201319578","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5135_CR97","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/092986611794578332","volume":"18","author":"DP Hong","year":"2011","unstructured":"Hong DP, Han S, Fink AL, Uversky VN (2011) Characterization of the non-fibrillar \u03b1-synuclein oligomers. Protein Pept Lett 18(3):230\u2013240","journal-title":"Protein Pept Lett"},{"issue":"5","key":"5135_CR98","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajpath.2023.01.010","volume":"193","author":"S Nuber","year":"2023","unstructured":"Nuber S, Selkoe DJ (2023) The Parkinson-associated toxin paraquat shifts physiological \u03b1-synuclein tetramers toward monomers that can be calpain-truncated and form oligomers. Am J Pathol 193(5):520\u2013531","journal-title":"Am J Pathol"},{"key":"5135_CR99","doi-asserted-by":"crossref","unstructured":"Konnova EA, Swanberg M (2018) Animal Models of Parkinson\u2019s Disease. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Brisbane (AU): Codon Publications Copyright: The Authors; 2018","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch5"},{"issue":"5646","key":"5135_CR100","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) \u03b1-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841","journal-title":"Science"},{"issue":"9","key":"5135_CR101","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM (2017) Animal models of \u03b1-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci 18(9):515\u2013529","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"5135_CR102","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/jnc.14806","volume":"150","author":"M Delenclos","year":"2019","unstructured":"Delenclos M, Burgess JD, Lamprokostopoulou A, Outeiro TF, Vekrellis K, McLean PJ (2019) Cellular models of alpha-synuclein toxicity and aggregation. J Neurochem 150(5):566\u2013576","journal-title":"J Neurochem"},{"issue":"6","key":"5135_CR103","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","volume":"16","author":"L Studer","year":"2015","unstructured":"Studer L, Vera E, Cornacchia D (2015) Programming and reprogramming cellular age in the era of induced pluripotency. Cell Stem Cell 16(6):591\u2013600","journal-title":"Cell Stem Cell"},{"issue":"10","key":"5135_CR104","doi-asserted-by":"publisher","first-page":"109189","DOI":"10.1016\/j.celrep.2021.109189","volume":"35","author":"E Kara","year":"2021","unstructured":"Kara E, Crimi A, Wiedmer A, Emmenegger M, Manzoni C, Bandres-Ciga S et al (2021) An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of \u03b1-synuclein. Cell Rep 35(10):109189","journal-title":"Cell Rep"},{"issue":"3","key":"5135_CR105","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. Faseb J 20(3):419\u2013425","journal-title":"Faseb J"},{"issue":"1","key":"5135_CR106","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.expneurol.2007.05.022","volume":"209","author":"MR Cookson","year":"2008","unstructured":"Cookson MR, van der Brug M (2008) Cell systems and the toxic mechanism(s) of \u03b1-synuclein. Exp Neurol 209(1):5\u201311","journal-title":"Exp Neurol"},{"issue":"14","key":"5135_CR107","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1074\/jbc.M208641200","volume":"278","author":"H Snyder","year":"2003","unstructured":"Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B (2003) Aggregated and monomeric alpha-synuclein bind to the S6\u2019 proteasomal protein and inhibit proteasomal function. J Biol Chem 278(14):11753\u201311759","journal-title":"J Biol Chem"},{"issue":"13","key":"5135_CR108","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, H\u00f8jrup P, Moos T, Gai W, Hendil KB et al (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279(13):12924\u201312934","journal-title":"J Biol Chem"},{"issue":"7","key":"5135_CR109","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb3372","volume":"18","author":"JG Lee","year":"2016","unstructured":"Lee JG, Takahama S, Zhang G, Tomarev SI, Ye Y (2016) Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. Nat Cell Biol 18(7):765\u2013776","journal-title":"Nat Cell Biol"},{"issue":"1","key":"5135_CR110","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-022-01468-8","volume":"10","author":"MF Altay","year":"2022","unstructured":"Altay MF, Liu AKL, Holton JL, Parkkinen L, Lashuel HA (2022) Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Acta Neuropathol Commun 10(1):163","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"5135_CR111","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2990.2001.00345.x","volume":"27","author":"N Hishikawa","year":"2001","unstructured":"Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson\u2019s disease. Neuropathol Appl Neurobiol 27(5):362\u2013372","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"5135_CR112","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/jnnp.68.5.605","volume":"68","author":"M Shoji","year":"2000","unstructured":"Shoji M, Harigaya Y, Sasaki A, U\u00e9da K, Ishiguro K, Matsubara E et al (2000) Accumulation of NACP\/alpha-synuclein in lewy body disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 68(5):605\u2013608","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"5135_CR113","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/PL00007441","volume":"99","author":"A Takeda","year":"2000","unstructured":"Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Masliah E (2000) C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol 99(3):296\u2013304","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5135_CR114","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00401-002-0622-9","volume":"105","author":"S Terada","year":"2003","unstructured":"Terada S, Ishizu H, Yokota O, Tsuchiya K, Nakashima H, Ishihara T et al (2003) Glial involvement in diffuse Lewy body disease. Acta Neuropathol 105(2):163\u2013169","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5135_CR115","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol 99(1):14\u201320","journal-title":"Acta Neuropathol"},{"issue":"3","key":"5135_CR116","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of \u03b1-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114(3):231\u2013241","journal-title":"Acta Neuropathol"},{"issue":"3","key":"5135_CR117","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/nan.12501","volume":"45","author":"YY Fathy","year":"2019","unstructured":"Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM et al (2019) Differential insular cortex subregional vulnerability to \u03b1-synuclein pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 45(3):262\u2013277","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5135_CR118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","volume":"69","author":"GG Kovacs","year":"2014","unstructured":"Kovacs GG, Breydo L, Green R, Kis V, Puska G, L\u0151rincz P et al (2014) Intracellular processing of disease-associated \u03b1-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis 69:76\u201392","journal-title":"Neurobiol Dis"},{"issue":"10","key":"5135_CR119","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","volume":"68","author":"YJ Song","year":"2009","unstructured":"Song YJ, Halliday GM, Holton JL, Lashley T, O\u2019Sullivan SS, McCann H et al (2009) Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J Neuropathol Exp Neurol 68(10):1073\u20131083","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"5135_CR120","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","volume":"7","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Goodwin MS, Riffe CJ, Dhillon JS, Xia Y, Gorion KM et al (2019) Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression. Acta Neuropathol Commun 7(1):142","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"5135_CR121","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","volume":"16","author":"EH Rannikko","year":"2015","unstructured":"Rannikko EH, Weber SS, Kahle PJ (2015) Exogenous \u03b1-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci 16(1):57","journal-title":"BMC Neurosci"},{"issue":"1","key":"5135_CR122","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2047-9158-2-20","volume":"2","author":"N Braidy","year":"2013","unstructured":"Braidy N, Gai W-P, Xu YH, Sachdev P, Guillemin GJ, Jiang X-M et al (2013) Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neurodegen 2(1):20","journal-title":"Transl Neurodegen"},{"issue":"3","key":"5135_CR123","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1471-4159.2005.03247.x","volume":"94","author":"PI Castagnet","year":"2005","unstructured":"Castagnet PI, Golovko MY, Barcel\u00f3-Coblijn GC, Nussbaum RL, Murphy EJ (2005) Fatty acid incorporation is decreased in astrocytes cultured from \u03b1-synuclein gene-ablated mice. J Neurochem 94(3):839\u2013849","journal-title":"J Neurochem"},{"key":"5135_CR124","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nbd.2017.04.011","volume":"103","author":"F Cavaliere","year":"2017","unstructured":"Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M et al (2017) In vitro \u03b1-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiol Dis 103:101\u2013112","journal-title":"Neurobiol Dis"},{"issue":"5","key":"5135_CR125","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cellsig.2013.12.020","volume":"26","author":"J Chen","year":"2014","unstructured":"Chen J, Yan H, Ren D-N, Yin Y, Li Z, He Q et al (2014) LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation. Cellular Signal 26(5):1068\u20131074","journal-title":"Cellular Signal"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05135-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:13:54Z","timestamp":1707131634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05135-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05135-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Primary cell lines were obtained within study protocols approved by the medical ethical committee of Erasmus MC and conformed to the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The participating human subjects provided written informed consent for the use of the material for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The participating human subjects provided written informed consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"75"}}